Acetylsalicylic acid: Difference between revisions
(Created page with "{{:Stub}} '''Acetylsalicylic acid''' (ASA) is technically an NSAID, although it’s more frequently used as an antiplatelet rather than for its anti-inflammatory effects. It’s a very frequently used antiplatelet. ASA is given in much lower dose for use as an antiplatelet drug than when used as an anti-inflammatory. Antiplatelet dose is 50 – 150 mg/day and in an extended-release formulation (Albyl-E®) while anti-inflammatory dose is 500 m...") |
No edit summary |
||
| Line 1: | Line 1: | ||
{{:Stub}} | {{:Stub}} | ||
'''Acetylsalicylic acid''' (ASA) is technically an [[NSAID]], although it’s more frequently used as an [[Antiplatelet drugs|antiplatelet]] rather than for its anti-inflammatory effects. It’s a very frequently used antiplatelet. | <section begin="clinical biochemistry" />'''Acetylsalicylic acid''' (ASA) is technically an [[NSAID]], although it’s more frequently used as an [[Antiplatelet drugs|antiplatelet]] rather than for its anti-inflammatory effects. It’s a very frequently used antiplatelet.<section end="clinical biochemistry" /> | ||
ASA is given in much lower dose for use as an antiplatelet drug than when used as an anti-inflammatory. Antiplatelet dose is 50 – 150 mg/day and in an extended-release formulation (Albyl-E®) while anti-inflammatory dose is 500 mg/day (Aspirin®). ASA has no anti-inflammatory effect in these low antiplatelet doses (although it does have an antiplatelet effect in the anti-inflammatory dose). | ASA is given in much lower dose for use as an antiplatelet drug than when used as an anti-inflammatory. Antiplatelet dose is 50 – 150 mg/day and in an extended-release formulation (Albyl-E®) while anti-inflammatory dose is 500 mg/day (Aspirin®). ASA has no anti-inflammatory effect in these low antiplatelet doses (although it does have an antiplatelet effect in the anti-inflammatory dose). | ||
<noinclude>[[Category:Pharmacology]] | |||
<section begin="clinical biochemistry" />One can monitor ASA therapeutic effect with [[platelet aggregometry]] with arachidonic acid, but this is not routinely performed. There are no known uses for this, as a therapeutic reference range has not been established.<section end="clinical biochemistry" /> | |||
<noinclude> | |||
[[Category:Pharmacology]] | |||
</noinclude> | </noinclude> | ||
Latest revision as of 13:00, 28 April 2024
This article is a stub, meaning that it is unfinished. It will eventually be expanded.
Acetylsalicylic acid (ASA) is technically an NSAID, although it’s more frequently used as an antiplatelet rather than for its anti-inflammatory effects. It’s a very frequently used antiplatelet.
ASA is given in much lower dose for use as an antiplatelet drug than when used as an anti-inflammatory. Antiplatelet dose is 50 – 150 mg/day and in an extended-release formulation (Albyl-E®) while anti-inflammatory dose is 500 mg/day (Aspirin®). ASA has no anti-inflammatory effect in these low antiplatelet doses (although it does have an antiplatelet effect in the anti-inflammatory dose).
One can monitor ASA therapeutic effect with platelet aggregometry with arachidonic acid, but this is not routinely performed. There are no known uses for this, as a therapeutic reference range has not been established.